← Back to Analyst Consensus 
OSCR Hold
Oscar Health, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Sep 18, 2026 | Raymond James | maintain | Outperform → Outperform | — | 54% |
| Sep 17, 2026 | B of A Securities | maintain | Underperform → Underperform | — | 53% |
| Sep 17, 2026 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | — | 54% |
| Sep 17, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 17, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Aug 13, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 7, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jun 10, 2026 | Barclays | upgrade | Equal-Weight → Overweight | — | 53% |
| May 26, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| May 7, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| May 7, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| May 7, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| May 6, 2026 | Wolfe Research | initiate | — → Peer Perform | — | 54% |
| Apr 20, 2026 | Jefferies | upgrade | Underperform → Hold | — | 52% |
| Jan 9, 2026 | UBS | upgrade | Sell → Neutral | $17 | 54% |
| Jan 5, 2026 | Barclays | upgrade | Underweight → Equal-Weight | $18 | 53% |
| Dec 11, 2025 | Stephens & Co. | initiate | — → Equal-Weight | $17 | 54% |
| Nov 26, 2025 | Piper Sandler | upgrade | Neutral → Overweight | $25 | 54% |
| Nov 13, 2025 | Wells Fargo | maintain | Underweight → Underweight | $11 | 54% |
| Nov 10, 2025 | Barclays | maintain | Underweight → Underweight | $13 | 53% |
| Nov 7, 2025 | UBS | maintain | Sell → Sell | $12 | 54% |
| Oct 14, 2025 | Goldman Sachs | initiate | — → Neutral | $17 | 54% |
| Oct 7, 2025 | Wells Fargo | maintain | Underweight → Underweight | $14 | 54% |
| Aug 14, 2025 | Piper Sandler | maintain | Neutral → Neutral | $13 | 54% |
| Jul 25, 2025 | Baird | downgrade | Outperform → Neutral | $14 | 55% |
| Jul 23, 2025 | Barclays | maintain | Underweight → Underweight | $11 | 53% |
| Jul 15, 2025 | UBS | downgrade | Neutral → Sell | $11 | 54% |
| Jul 11, 2025 | Wells Fargo | downgrade | Equal-Weight → Underweight | $10 | 54% |
| Jul 2, 2025 | Barclays | initiate | — → Underweight | $17 | 53% |
| Jun 9, 2025 | Piper Sandler | maintain | Overweight → Overweight | $18 | 54% |
| Mar 13, 2025 | Wells Fargo | downgrade | Overweight → Equal-Weight | $16 | 54% |
| Dec 10, 2024 | Jefferies | initiate | — → Underperform | $12 | 52% |
| Nov 6, 2024 | B of A Securities | downgrade | Neutral → Underperform | $13.5 | 53% |
| Oct 7, 2024 | UBS | initiate | — → Neutral | $23 | 54% |
| Sep 10, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $28 | 54% |
| Aug 8, 2024 | Piper Sandler | maintain | Overweight → Overweight | $28 | 54% |
| Jul 10, 2024 | Piper Sandler | maintain | Overweight → Overweight | $25 | 54% |
| Jun 26, 2024 | Piper Sandler | initiate | — → Overweight | $25 | 54% |
| Jun 12, 2024 | Wells Fargo | maintain | Overweight → Overweight | $27 | 54% |
| May 30, 2024 | B of A Securities | downgrade | Buy → Neutral | $21 | 53% |
| May 30, 2024 | Baird | initiate | — → Outperform | $28 | 55% |
| May 20, 2024 | B of A Securities | maintain | Buy → Buy | $25 | 53% |
| May 9, 2024 | Wells Fargo | maintain | Overweight → Overweight | $24 | 54% |
| May 9, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $21 | 54% |
| Mar 22, 2024 | Raymond James | initiate | — → Outperform | $20 | 54% |
| Feb 15, 2024 | Wells Fargo | maintain | Overweight → Overweight | $20 | 54% |
| Feb 9, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $16 | 54% |
| Feb 8, 2024 | B of A Securities | maintain | Buy → Buy | $20 | 53% |
Price Target Trend
Jun 4, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days